Dr. Smitha C Saldanha

Dr. Smitha C Saldanha

Dr. Smitha C Saldanha

QualificationMBBS, MD (General Medicine), DM (Medical Oncology), Fellowship in BMT

Specialities Medical Oncology

Locations HCG Cancer Center - KR BLR
Book an Appointment


Dr. Smitha is a highly trained and certified expert in haemato oncology and bone marrow transplantation. She specialises in treating a wide range of cancers, including breast cancer, leukaemias, lymphomas, multiple myeloma, gastrointestinal cancers, genitourinary cancers, head and neck cancers, and lung cancers. She also has an interest in treating paediatric tumours. Dr. Smitha is committed to providing individualised care to each patient, tailored to their unique needs.

Area of Expertise

  • Dr. Smitha’s primary interest is in haemato oncology & bone marrow transplantation (BMT).             
  • She also has interest in treating paediatric tumours.          
  • Her expertise lies mainly in treating breast cancer, leukemias, lymphomas, multiple myeloma, gastrointestinal cancers, genitourinary cancers, head & neck cancers and lung cancers.        
  • Dr. Smitha attends over 5000 cases every year.                              

Research & Publications

  • Study on Awareness among School Children on the spread, symptoms, treatment and prevention of Malaria in an urban endemic area of South India. Karnataka Paediatric Journal, 24 (1), January-March 2010: p 4-6
  • A Study on the Awareness observed among Individuals living in Endemic Area on the Spread, Symptoms, Treatment and prevention of Malaria. Al Ameen J Med Sci 4 (1), January-March 2011: p 80-83
  • An Interesting Case Report on Cerebellar and Psychiatric Manifestations in Malaria. Journal of Clinical and Diagnostic Research, October 2011, 5 (5): 1104-6
  • Extermination of the Smallpox Virus – Light at the End of the Tunnel… or not – the Stalemate Continues. Annals of Community Health, 2014 Apr; 2 (2): 2-3.
  • Langerhans Cell Sarcoma – Review of Literature and a Rare Case Report . J Mol BiomarkDiagn2014; 5:181.
  • Plasmablastic lymphoma of bone in a human immunodeficiency virus positive child – A rare extra-oral presentation. Pediatric Infectious Disease, 2014;  6 (4), 142 – 144
  • Epigenetic therapy of cancer with histonedeacetylase inhibitors. Journal of Cancer Research and Therapeutics, 2014; 10 ( 3): 469-478
  • A study of comparison of prognostic models in peripheral T cell lymphoma in a tertiary care centre in South India. Annals of Oncology 26 (Supplement 9): ix85–ix92, 2015
  • The Efficacy, safety and cost benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: a pilot study from south India. Chemotherapy Research and Practice, vol. 2016, Article ID 3439707, 2016.
  • Hairy Cell Leukemia – Clinical Profile and treatment outcome from a tertiary regional cancer institute in South India. Clin Cancer InvestigJ, 2016; 5:141-5.
  • Breast cancer as second malignant neoplasm after acute myeloid leukemia: A rare occurence.Clin Cancer investig J, 2016; 333-5. 
  • Gemcitabine – induced supraventricular tachycardia: A rare manifestation. Clin Cancer Investig J 2016; 5:200-2.
  • Clinicopathological profile of pure Neuroendocrineneoplasms of the Esophagus: A South Indian center experience. Journal of Oncology

Medical Breakthrough

  • NITTE Education Trust Award – Gold Medal and Highest marks in Community Medicine, RGUHS, 2003
  • NITTE Education Trust Award – Gold Medal and Highest marks in ENT, RGUHS, 2003.
  • ESMO ASIA 2015 ISMPO travel grant at ISMPOCON, Mumbai, Nov 2015.
  • Best Poster Award at the ISMPOCON, Mumbai, Nov 2015. 
  • Pfizer grant for Research Hypothesis presentation at ISMPOCON Nov 2016.
  • RCC Perceptorship programme at Taiwan.
  • ESMO Preceptorship on Metastatic Bladder and Kidney Cancer - Multidisciplinary management, standards of care, therapeutic targets and future perspectives, 19-20 September 2018, Singapore.
  • ESMO Preceptorship on Non-Small-Cell Lung Cancer - Standards of care, evolving paradigm and future perspectives, 21-22 November 2018, Singapore.
  • ESMO Preceptorship on Immuno-Oncology - From the essentials of tumour immunology to clinical application,26-27 November 2018, Singapore.
  • Presentation at ESMO Congress 2019 at Spain
  • IASLC WCLC 2019 at Spain

Awards & Accolades

  • ESMO exam for medical oncologists from the European Society of Medical Oncology in 2017            
  • Fellowship training in Bone Marrow Transplantation in 2019                              

Other Doctors